Brighton Jones LLC boosted its position in MetLife, Inc. (NYSE:MET – Free Report) by 30.1% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 5,902 shares of the financial services provider’s stock after buying an additional 1,366 shares during the period. Brighton Jones LLC’s holdings in MetLife were worth $475,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also bought and sold shares of the company. North Capital Inc. acquired a new position in MetLife in the first quarter valued at $26,000. Motco lifted its holdings in MetLife by 105.5% in the first quarter. Motco now owns 413 shares of the financial services provider’s stock valued at $33,000 after buying an additional 212 shares during the period. GFG Capital LLC acquired a new position in MetLife in the second quarter valued at $38,000. Abound Wealth Management lifted its holdings in MetLife by 652.3% in the second quarter. Abound Wealth Management now owns 489 shares of the financial services provider’s stock valued at $39,000 after buying an additional 424 shares during the period. Finally, Legend Financial Advisors Inc. acquired a new position in MetLife in the second quarter valued at $40,000. Institutional investors and hedge funds own 94.99% of the company’s stock.
MetLife Stock Down 0.6%
Shares of NYSE:MET opened at $78.30 on Thursday. The stock has a market cap of $52.07 billion, a price-to-earnings ratio of 13.27, a PEG ratio of 0.71 and a beta of 0.86. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.57. MetLife, Inc. has a 12-month low of $65.21 and a 12-month high of $89.05. The business’s 50 day moving average is $80.39 and its 200 day moving average is $78.53.
MetLife Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 9th. Shareholders of record on Tuesday, November 4th will be given a $0.5675 dividend. This represents a $2.27 dividend on an annualized basis and a yield of 2.9%. The ex-dividend date of this dividend is Tuesday, November 4th. MetLife’s dividend payout ratio is presently 38.47%.
Wall Street Analyst Weigh In
Several equities analysts recently issued reports on the stock. Jefferies Financial Group boosted their target price on shares of MetLife from $100.00 to $103.00 and gave the company a “buy” rating in a report on Monday, August 11th. JPMorgan Chase & Co. lifted their price target on shares of MetLife from $86.00 to $95.00 and gave the company an “overweight” rating in a research note on Tuesday, July 8th. Weiss Ratings reaffirmed a “buy (b)” rating on shares of MetLife in a research note on Wednesday, October 8th. Cowen reaffirmed a “buy” rating on shares of MetLife in a research note on Friday, August 22nd. Finally, Keefe, Bruyette & Woods decreased their price target on shares of MetLife from $94.00 to $92.00 and set an “outperform” rating for the company in a research note on Monday, August 11th. One research analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and two have given a Hold rating to the stock. According to MarketBeat.com, MetLife currently has a consensus rating of “Moderate Buy” and an average price target of $95.18.
Get Our Latest Stock Analysis on MET
MetLife Company Profile
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Recommended Stories
- Five stocks we like better than MetLife
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- These 3 High-Momentum ETFs Are Riding the Tech Wave
- Conference Calls and Individual Investors
- Verizon Results Trigger Rebound in High-Yield Stock
- How to Profit From Value Investing
- Picks & Shovels: Investing in the Physical Foundation of AI
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.
